Novel Screening Assay for the Selective Detection of G-Protein-Coupled Receptor Heteromer Signaling

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2013-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.112.198655PMID 23097213PMCID PMC3533407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure of the human kappa opioid receptor in complex with JDTic

  2012influential reference
• Crystal structure of the μ-opioid receptor bound to a morphinan antagonist

  2012cited by this paper
• Structure of the δ-opioid receptor bound to naltrindole

  2012cited by this paper
• Structure of the human k-opioid receptor in complex with JDTic

  2012influential reference
• Protein–protein interaction inhibitors get into the groove

  2012cited by this paper
• How were new medicines discovered?

  2011cited by this paper
• Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.

  2011cited by this paper
• Facilitation of m-Opioid Receptor Activity by Preventing d-Opioid Receptor- Mediated Codegradation

  2011cited by this paper
• Therapeutic potential of β-arrestin- and G protein-biased agonists.

  2011cited by this paper
• Asymmetry of GPCR oligomers supports their functional relevance.

  2011cited by this paper
• Helix 8 Plays a Crucial Role in Bradykinin B2 Receptor Trafficking and Signaling

  2011cited by this paper
• Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists

  2010cited by this paper
• From the Cover: Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation

  2010cited by this paper
• Neurocircuitry of Addiction

  2010cited by this paper
• G protein-coupled receptor heteromers as new targets for drug development.

  2010cited by this paper
• G protein-coupled receptors: novel targets for drug discovery in cancer

  2010cited by this paper
• Increased Abundance of Opioid Receptor Heteromers After Chronic Morphine Administration

  2010cited by this paper
• Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

  2009cited by this paper
• In Vivo Delta Opioid Receptor Internalization Controls Behavioral Effects of Agonists

  2009cited by this paper
• Allosteric communication between protomers of dopamine Class A GPCR dimers modulates activation

  2009cited by this paper
• Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine.

  2009cited by this paper
• Molecular Dynamics Simulation of the Heterodimeric mGluR2/5HT2A Complex. An Atomistic Resolution Study of a Potential New Target in Psychiatric Conditions

  2009cited by this paper
• Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859).

  2008cited by this paper
• Cloning and characterization of dominant negative splice variants of the human histamine H4 receptor.

  2008cited by this paper
• G protein-coupled receptor dimers: functional consequences, disease states and drug targets.

  2008cited by this paper
• A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein

  2007cited by this paper
• An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor Function

  2007cited by this paper
• Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs.

  2007cited by this paper
• Novel pharmacological applications of G-protein-coupled receptor-G protein fusions.

  2007cited by this paper
• Crystal structure of a photoactivated deprotonated intermediate of rhodopsin

  2006cited by this paper
• How many drug targets are there?

  2006cited by this paper
• Do orphan G‐protein‐coupled receptors have ligand‐independent functions?

  2006cited by this paper
• A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia.

  2004cited by this paper
• The basic residues in the membrane-proximal C-terminal tail of the rat melanin-concentrating hormone receptor 1 are required for receptor function.

  2004cited by this paper
• A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia

  2004cited by this paper
• The evolutionarily triumphant G-protein-coupled receptor.

  2003cited by this paper
• Atomic-force microscopy: Rhodopsin dimers in native disc membranes

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Probes for Narcotic Receptor Mediated Phenomena

  2003cited by this paper
• Value of novelty?

  2002cited by this paper
• Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness

  2001cited by this paper
• Is Galpha16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors?

  2001cited by this paper
• Functional coupling with Galpha(q) and Galpha(i1) protein subunits promotes high-affinity agonist binding to the neurotensin receptor NTS-1 expressed in Escherichia coli.

  2001cited by this paper
• Functional coupling with Gαq and Gαi1 protein subunits promotes high‐affinity agonist binding to the neurotensin receptor NTS‐1 expressed in Escherichia coli

  2001cited by this paper
• Is Gα16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors?

  2001cited by this paper
• Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice.

  1999cited by this paper
• Retention of Supraspinal Delta-like Analgesia and Loss of Morphine Tolerance in δ Opioid Receptor Knockout Mice

  1999cited by this paper
• Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors.

  1999cited by this paper
• International Union of Pharmacology. XIII. Classification of histamine receptors.

  1997cited by this paper
• Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist.

  1994cited by this paper
• Substitution of three amino acids switches receptor specificity of Gqα to that of Giα

  1993cited by this paper
• Involvement of delta 2 opioid receptors in the development of morphine dependence in mice.

  1993cited by this paper
• Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha.

  1993cited by this paper
• Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors.

  1989cited by this paper

• Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery II

  2022cites this paper
• Profiling novel pharmacology of receptor complexes using Receptor-HIT

  2021cites this paper
• A critical evaluation of TRPA1-mediated locomotor behavior in zebrafish as a screening tool for novel anti-nociceptive drug discovery

  2019cites this paper
• Role of Corticotropin Releasing Factor Binding Protein in the stress system: a strange case of Dr. Jekyll and Mr. Hyde in the stress system?:

  2018cites this paper
• Functional histamine H3 and adenosine A2A receptor heteromers in recombinant cells and rat striatum

  2017cites this paper
• INVESTIGATING THE EFFECTS OF PROLONGED MU OPIOID RECEPTOR ACTIVATION UPON OPIOID RECEPTOR HETEROMERIZATION

  2017cites this paper
• The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system?

  2017cites this paper
• β‐Arrestin 2 dependence of δ opioid receptor agonists is correlated with alcohol intake

  2016cites this paper
• The Histamine H3 Receptor: Structure, Pharmacology, and Function

  2016cites this paper
• Untersuchungen zur funktionellen Interaktion zwischen dem Rezeptor Mas und dem AT2-Rezeptor in primären, murinen Astrozyten

  2015cites this paper
• Heteromers of μ‐δ opioid receptors: new pharmacology and novel therapeutic possibilities

  2015influential citation
• A G Protein–Coupled Receptor Dimer Imaging Assay Reveals Selectively Modified Pharmacology of Neuropeptide Y Y1/Y5 Receptor Heterodimers

  2015cites this paper
• Evaluating the Phase II drugs currently under investigation for diabetic neuropathy

  2015cites this paper
• Role of opioid receptor heterodimerization in pain modulation and tolerance development

  2015cites this paper
• REVIEW Heteromers of μ - δ opioid receptors: new pharmacology and novel therapeutic possibilities

  2014influential citation
• Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors

  2014cites this paper
• G-protein-coupled receptors oligomerization: emerging signaling units and new opportunities for drug design.

  2014cites this paper
• Endogenous opiates and behavior: 2013.

  2014cites this paper
• Knockout subtraction autoradiography: a novel ex vivo method to detect heteromers finds sparse KOP receptor/DOP receptor heterodimerization in the brain.

  2014cites this paper
• Les récepteurs couplés aux protéines G sous les feux de la rampe

  2013cites this paper
• Class A G-protein-coupled receptor (GPCR) dimers and bivalent ligands.

  2013cites this paper
• [G protein-coupled receptors in the spot light].

  2013cites this paper